Clicky

GENOVIS AB SE-40(5GV)

Description: Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries. The company provides FabALACTICA, a cysteine protease; FabRICATOR, a cysteine protease; and FabRICATOR Z, for the digestion of mouse IgG2a and IgG3, and generating a homogenous pool of F(ab')2 and Fc fragments. It offers FabULOUS (SpeB), a cysteine protease; GingisKHAN, a cysteine protease; FabDELLO, a protease that digests human IgG1; IgASAP, an IgA-digesting enzyme; and IgMBRAZOR, an IgM-specific protease. In addition, the company offers GingisREX, a protease that digests proteins C-terminally of arginine residues; GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology; TransGLYCIT, a platform technology; OmniGLYZOR, a mixture of immobilized enzymes; PNGase F, a glycoamidase; and OpeRATOR, an O-glycan-specific protease. Further, it provides OglyZOR, an endoglycosidase; SialEXO, a sialidase product; FucosEXO, a mix of a-Fucosidases; GalactEXO, a ß-Galactosidase mix; GalNAcEXO, an a-N-Acetylgalactosaminidase; GlycOCATCH, an affinity resin; GlycINATOR (EndoS2), an IgG-specific endoglycosidase; IgGZERO (EndoS), an IgG-specific endoglycosidase; Anti-FabRICATOR (Anti-IdeS), a goat polyclonal antibody; and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody. Additionally, the company offers antibodies, assay kits, reagents, and cell culture products; bioprocess and gene therapy services; and services, such as SmartEnzymes fragmentation and conjugation, antibody LC-MS analysis, and customized antibody services, as well as operates an online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Europe, North America, and Asia. The company was founded in 1999 and is headquartered in Kävlinge, Sweden.


Keywords: Immunology Antibodies Gene Therapy Contract Manufacturing Enzymes Glycoproteins Platform Technology Polyclonal Antibodies Immunoglobulin G Glycine Gene Therapy Services Endo S Fab Alactica Gingis Rex Proteases Sialidase Product

Home Page: www.genovis.com

Box 4
Kävlinge, 244 21
Sweden
Phone: 46 46 10 12 30


Officers

Name Title
Mr. Fredrik Olsson President & CEO
Mr. Magnus Langberg Group Chief Financial Officer
Ms. Rikke Rytter Vice President of Sales & Marketing
Ms. Maria Edholm Controller
Mr. John M. Lindsay B.A., BA President of Genovis Inc.

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 50.5
Price-to-Book MRQ: 6.8398
Price-to-Sales TTM: 1.0693
IPO Date:
Fiscal Year End: December
Full Time Employees: 37
Back to stocks